Heart rate variability as an indicator of COVID-19 induced myocardial injury.

Heart rate variability as an indicator of COVID-19 induced myocardial injury. - Heart rate variability indicated COVID associated myocardial injury myocardial injury.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045384

Enrollment

Registered

2022-01-10

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury that results as a complication of COVID 19 infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a) age between 18-65 years; b)confirmed COVID 19 infection; c)myocardial injury diagnosed by three different methods (elevated cardiac enzymes, ECG changes and abnormal ECHO changes); d) onset of myocardial affection within 1 week of admission.

Exclusion criteria

Exclusion criteria: a) patients with known cardiac disease (IHD, CHF, myocarditis or arrythmias) within last six months prior COVID 19 infection; b) patients with metabolic, autoimmune diseases and diabetes mellites; c) patients with poor physical compliance; d) patients with incomplete clinical data.

Design outcomes

Primary

Measure	Time frame
confirmation the incidence of heart rate variability in COVID 19 infection	—

Countries

Africa

Contacts

Public ContactHANI TAMAN

MANSOURA FACULTY OF MEDICINE, MANSOURA UNIVERSITY, MANSOURA, EGYPT ANAETHESIA DEPARTMENT

han_taman@yahoo.com01008288242

Outcome results